Now Funding

AquiNovo

Non-GMO, non-hormonal technology for accelerating fish growth • Shorter time to market, increased yields > increased revenues • Estimated market potential: 50+million tonnes • Read more >

CorAlert

Noninvasive monitor managing heart failure (HF) • U.S.: 5.7 million suffer from HF • IP: Filed U.S. patent • Successful alpha clinical trial • Read more >

EdenShield

Patented, eco-friendly plant-based alternative to chemical pesticides • Successful trials: nearly 100% insect blockage • Field trials with leading growers and IPM leaders • Sales, distribution agreements • Crop insecticide market: $14 billion • Read more >

LapSpace Medical

Minimally invasive inflatable laparoscopic retractor • U.S. and EU: ~10 million laparoscopic procedures • Initial sales in Europe • Successful study at Johns Hopkins • FDA cleared, CE mark • Read more >

liberDi

Portable, smart dialysis system • Reduced risk of infection • Easy operation • U.S.: 3.2 million people with end-stage renal disease (ESRD) • U.S.: $30.9 billion Medicare spending on ESRD • Read more >

MiRobot

Robotic milking system • Proof of concept in dairy farm • 75% labor reduction • >40% throughput increase • Brings big data to dairy farmers • Addressable market: $4.6 billion • Read more >

OrthoSpin

Smart external fixation system • Highly accurate frame adjustments • Reduces dependency on patient compliance • Strong IP • Addressable market: $450 million circular/hexapod/other external fixation frames • Read more >

ProArc Medical

Minimally invasive ClearRing™ system for enlarged prostate (BPH) • U.S.: 12 million men treated for symptomatic BPH • Total available market potential for urethral lift: >$1.5 billion, 35% CAGR • Strong clinical evidence and 12-month supporting data • Read more >

Valentis Nanotech

Innovative new coatings • Applications for greenhouses, food packaging, electronics, construction materials • Very good results from scale-up trial • Collaborations with diverse international companies •  Read more >

ViAqua Therapeutics

Orally administered treatment to prevent diseases in aquaculture • Diseases cause 10% to 20% losses in shrimp aquaculture • Annual global shellfish market: $36 billion; 10% annual growth • Successful trials in United States, Thailand • Read more >

Font Resize
Contrast